Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03482310 · ClinicalTrials.gov registry record · NA
Restoring High Dimensional Hand Function to Persons With Chronic High Tetraplegia
A NA study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT03482310: Completed NA study, sponsored by VA Office of Research and Development.
NCT03482310 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 1 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03482310, a NA study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
This study is for people who have a paralyzed arm and hand from a spinal cord injury, who have also received a recording electrode array in the brain as part of the BrainGate study. The study will look at the ability of these participants to control different grasping patterns of the hand, both in virtual reality and in his/her actual hand. Movement of the participant's hand is controlled by a functional electrical stimulation (FES) system, which involves small electrodes implanted in the arm, shoulder and hand that use small electrical currents to activate the appropriate muscles.
Primary Outcome
The success rate for achieving a series of specified grasp patterns will be calculated. This will be a percentage of the target grasp patterns successfully achieved. The reported outcome is an average of the outcomes (mean +/- standard deviation) over the full assessment period
Interventions
- DEVICE Using the Neuroport cortical recording array to determine the desired grasp pattern for a functional electrical stimulation (FES) system
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2018-06-01 |
| Est. Completion | 2023-09-30 |
| Phase | NA |
What the finished NCT03482310 record still lists
NCT03482310 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Using the Neuroport cortical recording array to determine the desired grasp pattern for a functional electrical stimulation (FES) system is the first listed.
NCT03482310 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03482310 about?
NCT03482310 is a clinical study titled "Restoring High Dimensional Hand Function to Persons With Chronic High Tetraplegia". This study is for people who have a paralyzed arm and hand from a spinal cord injury, who have also received a recording electrode array in the brain as part of the BrainGate study. The study will look at the ability of these participants to control different grasping patterns of the hand, both in v...
What is the current status of trial NCT03482310?
This trial is currently completed. It is a NA study. The enrollment target is 1 participants. The study started on 2018-06-01. Estimated completion is 2023-09-30.
What interventions are being tested in trial NCT03482310?
The interventions under investigation include: Using the Neuroport cortical recording array to determine the desired grasp pattern for a functional electrical stimulation (FES) system (DEVICE).
Who is sponsoring clinical trial NCT03482310?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03482310's enrollment target sits among peer trials
1 2001st of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI